ANXA1 inhibits trophoblast ferroptosis in preeclampsia by downregulating KISS1
Biology of Reproduction · 2025
DOI: 10.1093/biolre/ioaf060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Reproduction, 2025. Verfasst von Yuzhu Rao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Coopera…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Annexin A1, Ferroptosis, Trophoblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Preeclampsia (PE) is a serious hypertensive disorder of pregnancy, significantly affecting maternal and neonatal health worldwide. It remains a leading cause of morbidity and mortality. Recent studies suggest a potential link between ferroptosis and PE. Annexin A1 (ANXA1), an endogenous anti-inflammatory mediator, can be activated by glucocorticoids, ischemia–reperfusion, inflammation, or oxidative stress. Ac2-26, a synthetic peptide derived from the N-terminal 26 amino acids of ANXA1, retains its anti-inflammatory properties. However, the regulatory mechanisms of ANXA1 in PE are not fully understood. In this study, we first observed in creased ferroptosis and reduced ANXA1 expression in preeclamptic placentas. A PE-like mouse model further confirmed placental ferroptosis, which was ameliorated by Ac2-26 treatment, improving pregnancy outcomes. In vitro, Ac2-26 targeted ANXA1, alleviated RSL 3-induced trophoblast dysfunction, and inhibited lipid peroxidation. Mechanistically, we found that increased KISS1 expression is closely associated with ferroptosis and PE, and that ANXA1 (Ac2-26) suppresses KISS1 expression, thereby mitigating ferroptosis. In summary, our findings identify a novel mechanism in which elevated KISS1 promotes ferroptosis in PE, and this process is counteracted by ANXA1 (Ac2-26) via KISS1 downregulation. This discovery offers a promising therapeutic strategy targeting ferroptosis in PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical College, Unive…
- Xiangtan Central Hospital, Fajian Hospital Area, 120 Heping Road, Xiangtan, Hunan, China.
- Department of Pediatrics, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.
- Cardiology Department, The Third Affiliated Hospital of University of South China, Hengyang, Hunan, China.
- Department of Obstetrics and Gynecology, Hengyang Maternal and Child Health Hospital, Hengyang, Hunan, China.
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Rao, Y., Tan, S., Wang, J., Jia, J., Cai, Z., Wu, C., Wu, P., & Wang, Z. (2025). ANXA1 inhibits trophoblast ferroptosis in preeclampsia by downregulating KISS1. Biology of Reproduction. https://doi.org/10.1093/biolre/ioaf060
Vancouver
Rao Y, Tan S, Wang J, Jia J, Cai Z, Wu C, et al. ANXA1 inhibits trophoblast ferroptosis in preeclampsia by downregulating KISS1. Biology of Reproduction. 2025. doi:10.1093/biolre/ioaf060
BibTeX
@article{Rao2025,
author = {Rao, Yuzhu and Tan, Shiming and Wang, Jingjing and Jia, Jingqiu and Cai, Zemin and Wu, Chunyan and Wu, Peng and Wang, Zuo},
title = {ANXA1 inhibits trophoblast ferroptosis in preeclampsia by downregulating KISS1},
journal = {Biology of Reproduction},
year = {2025},
doi = {10.1093/biolre/ioaf060}
}
EUVIMED